{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:16:39Z","timestamp":1791224199921,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.bcp.2012.02.026","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T01:46:58Z","timestamp":1330998418000},"page":"1602-1612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation"],"prefix":"10.1016","volume":"83","author":[{"given":"Robert A.","family":"Forrest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonnie P.","family":"Swift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Rephaeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Nudelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-Ichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don R.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Cutts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2012.02.026_bib0005","series-title":"Cancer principles and practice of oncology","author":"DeVita","year":"2005"},{"key":"10.1016\/j.bcp.2012.02.026_bib0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bcp.2012.02.026_bib0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.6093249","article-title":"Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II","volume":"226","author":"Tewey","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.bcp.2012.02.026_bib0020","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1021\/bi00475a032","article-title":"Induction of stable transcriptional blockage sites by adriamycin: GpC specificity of apparent adriamycin-DNA adducts and dependence on iron(III) ions","volume":"29","author":"Cullinane","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2012.02.026_bib0025","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1021\/jm960519z","article-title":"Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin","volume":"39","author":"Taatjes","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2012.02.026_bib0030","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1021\/bi00230a002","article-title":"Formaldehyde cross-links daunorubicin and DNA efficiently: HPLC and X-ray diffraction studies","volume":"30","author":"Wang","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2012.02.026_bib0035","doi-asserted-by":"crossref","first-page":"11561","DOI":"10.1073\/pnas.95.20.11561","article-title":"Characterization of covalent adriamycin-DNA adducts","volume":"95","author":"Zeman","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2012.02.026_bib0040","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1093\/nar\/gkn439","article-title":"Detection of adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant adriamycin concentrations","volume":"36","author":"Coldwell","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bcp.2012.02.026_bib0045","first-page":"8194","article-title":"Molecular basis for the synergistic interaction of adriamycin with the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate (AN-9)","volume":"61","author":"Cutts","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.02.026_bib0050","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1158\/1535-7163.MCT-06-0551","article-title":"Activation of clinically used anthracyclines by the formaldehyde-releasing prodrug pivaloyloxymethyl butyrate","volume":"6","author":"Cutts","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2012.02.026_bib0055","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1158\/0008-5472.CAN-05-3410","article-title":"Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death","volume":"66","author":"Swift","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.02.026_bib0060","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1021\/jm049428p","article-title":"The role of intracellularly released formaldehyde and butyric acid in the anticancer activity of acyloxyalkyl esters","volume":"48","author":"Nudelman","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2012.02.026_bib0065","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1021\/jm060597e","article-title":"Design, synthesis, and preliminary evaluation of doxazolidine carbamates as prodrugs activated by carboxylesterases","volume":"49","author":"Burkhart","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2012.02.026_bib0070","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1021\/jm900694z","article-title":"Preclinical efficacy of a carboxylesterase 2-activated prodrug of doxazolidine","volume":"52","author":"Barthel","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2012.02.026_bib0075","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1021\/jm970237e","article-title":"Daunoform: anthracycline-formaldehyde conjugates toxic to resistant tumor cells","volume":"40","author":"Fenick","year":"1997","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2012.02.026_bib0080","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00432-006-0116-6","article-title":"Mode of interaction between butyroyloxymethyl-diethyl phosphate (AN-7) and doxorubicin in MCF-7 and resistant MCF-7\/Dx cell lines","volume":"132","author":"Engel","year":"2006","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.bcp.2012.02.026_bib0085","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/sj.bjc.6603781","article-title":"Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicity","volume":"96","author":"Rephaeli","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2012.02.026_bib0090","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s10637-010-9542-z","article-title":"The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity","volume":"30","author":"Tarasenko","year":"2012","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.bcp.2012.02.026_bib0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: making it safe to play with knives","volume":"40","author":"Ciccia","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2012.02.026_bib0100","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.molcel.2007.11.015","article-title":"The DNA damage response: ten years after","volume":"28","author":"Harper","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2012.02.026_bib0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1172\/JCI6863","article-title":"Disruption of p53 in human cancer cells alters the responses to therapeutic agents","volume":"104","author":"Bunz","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2012.02.026_bib0110","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.7164\/antibiotics.40.1353","article-title":"SN-07 chromophore: an anthracycline antibiotic from the macromolecular antibiotic SN-07","volume":"40","author":"Kimura","year":"1987","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.bcp.2012.02.026_bib0115","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1021\/jm00082a009","article-title":"Novel anticancer prodrugs of butyric acid. 2","volume":"35","author":"Nudelman","year":"1992","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2012.02.026_bib0120","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-04-2727","article-title":"Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM","volume":"64","author":"Hickson","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.02.026_bib0125","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1128\/MCB.16.10.5245","article-title":"Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced, c-Myc-dependent apoptosis","volume":"16","author":"Janicke","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2012.02.026_bib0130","first-page":"1688","article-title":"Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects","volume":"62","author":"Zhou","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2012.02.026_bib0135","doi-asserted-by":"crossref","first-page":"9357","DOI":"10.1074\/jbc.273.16.9357","article-title":"Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis","volume":"273","author":"Janicke","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.02.026_bib0140","series-title":"Using antibodies: a laboratory manual","author":"Harlow","year":"1999"},{"key":"10.1016\/j.bcp.2012.02.026_bib0145","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/387296a0","article-title":"Mdm2 promotes the rapid degradation of p53","volume":"387","author":"Haupt","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2012.02.026_bib0150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0092-8674(00)80416-X","article-title":"DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2","volume":"91","author":"Shieh","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2012.02.026_bib0155","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1101\/gad.11.24.3471","article-title":"DNA damage induces phosphorylation of the amino terminus of p53","volume":"11","author":"Siliciano","year":"1997","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2012.02.026_bib0160","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1039\/P19960001327","article-title":"New anthracycline disaccharides. Synthesis of l-daunosaminyl-\u03b1(1\u20134)-2-deoxy-l-rhamnosyl and of l-daunosaminyl-\u03b1(1\u20134)-2-deoxy-l-fucosydl aunorubicin analogues","volume":"1","author":"Animati","year":"1996","journal-title":"J Chem Soc, Perkins Trans"},{"key":"10.1016\/j.bcp.2012.02.026_bib0165","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.7164\/antibiotics.38.1670","article-title":"A novel macromolecular antibiotic, SN-07 Taxonomy of producing organism, isolation, characterization and biological activities","volume":"38","author":"Kikuchi","year":"1985","journal-title":"J Antibiot"},{"key":"10.1016\/j.bcp.2012.02.026_bib0170","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1101\/gad.13.2.152","article-title":"A role for ATR in the DNA damage-induced phosphorylation of p53","volume":"13","author":"Tibbetts","year":"1999","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2012.02.026_bib0175","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1126\/science.281.5383.1674","article-title":"Enhanced phosphorylation of p53 by ATM in response to DNA damage","volume":"281","author":"Banin","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bcp.2012.02.026_bib0180","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1126\/science.281.5383.1677","article-title":"Activation of the ATM kinase by ionizing radiation and phosphorylation of p53","volume":"281","author":"Canman","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bcp.2012.02.026_bib0185","doi-asserted-by":"crossref","first-page":"20444","DOI":"10.1074\/jbc.M001020200","article-title":"ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation","volume":"275","author":"She","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.02.026_bib0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/138161210789941801","article-title":"Mechanisms of drug-induced mitotic catastrophe in cancer cells","volume":"16","author":"Portugal","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bcp.2012.02.026_bib0195","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/cdd.2008.47","article-title":"Death through a tragedy: mitotic catastrophe","volume":"15","author":"Vakifahmetoglu","year":"2008","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bcp.2012.02.026_bib0200","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.mrfmmm.2007.09.005","article-title":"DNA repair in response to anthracycline-DNA adducts: a role for both homologous recombination and nucleotide excision repair","volume":"638","author":"Spencer","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.bcp.2012.02.026_bib0205","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2012.02.026_bib0210","doi-asserted-by":"crossref","first-page":"53272","DOI":"10.1074\/jbc.M406879200","article-title":"Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species","volume":"279","author":"Kurz","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.02.026_bib0215","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrc1560","article-title":"The role of apoptosis in cancer development and treatment response","volume":"5","author":"Brown","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2012.02.026_bib0220","doi-asserted-by":"crossref","first-page":"a004887","DOI":"10.1101\/cshperspect.a004887","article-title":"p63 and p73, the ancestors of p53","volume":"2","author":"Dotsch","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.bcp.2012.02.026_bib0225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1541-7786.MCR-04-0209","article-title":"Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites","volume":"3","author":"Ishii","year":"2005","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bcp.2012.02.026_bib0230","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1751-1097.1993.tb09233.x","article-title":"Nucleotide excision repair","volume":"57","author":"Sancar","year":"1993","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.bcp.2012.02.026_bib0235","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.onc.1202356","article-title":"Inhibition of RNA polymerase II as a trigger for the p53 response","volume":"18","author":"Ljungman","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2012.02.026_bib0240","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/cr.2008.6","article-title":"Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects","volume":"18","author":"Fousteri","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.bcp.2012.02.026_bib0245","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1091\/mbc.e08-02-0215","article-title":"Transcription-coupled DNA double-strand breaks are mediated via the nucleotide excision repair and the Mre11-Rad50-Nbs1 complex","volume":"19","author":"Guirouilh-Barbat","year":"2008","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bcp.2012.02.026_bib0250","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nrm951","article-title":"Recombinational repair and restart of damaged replication forks","volume":"3","author":"McGlynn","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bcp.2012.02.026_bib0255","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nrm1493","article-title":"Checking on DNA damage in S phase","volume":"5","author":"Bartek","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bcp.2012.02.026_bib0260","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/sj.emboj.7600113","article-title":"The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways","volume":"23","author":"Pichierri","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2012.02.026_bib0265","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm2450","article-title":"ATR: an essential regulator of genome integrity","volume":"9","author":"Cimprich","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bcp.2012.02.026_bib0290","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4161\/cc.9.4.10764","article-title":"\u03b3H2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization","volume":"9","author":"L\u00f6brich","year":"2010","journal-title":"Cell Cycle."},{"key":"10.1016\/j.bcp.2012.02.026_bib0295","doi-asserted-by":"crossref","unstructured":"Bilardi RA, Kimura KI, Phillips DR, Cutts SM. Processing of anthracycline-DNA adducts via DNA replication and interstrand crosslink repair pathways. Biochem Pharmacol. 2012 Feb 2 [Epub ahead of print].","DOI":"10.1016\/j.bcp.2012.01.029"},{"key":"10.1016\/j.bcp.2012.02.026_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/jcs.01626","article-title":"G2 damage checkpoints: what is the turn-on","volume":"118","author":"O\u2019Connell","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bcp.2012.02.026_bib0275","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/cyto.a.20241","article-title":"Effects of hydroxyurea and aphidicolin on phosphorylation of ataxia telangiectasia mutated on Ser 1981 and histone H2AX on Ser 139 in relation to cell cycle phase and induction of apoptosis","volume":"69","author":"Kurose","year":"2006","journal-title":"Cytometry A"},{"key":"10.1016\/j.bcp.2012.02.026_bib0280","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1074\/jbc.M109.076109","article-title":"Interactions of human mismatch repair proteins MutSalpha and MutLalpha with proteins of the ATR-Chk1 pathway","volume":"285","author":"Liu","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.02.026_bib0285","doi-asserted-by":"crossref","first-page":"19237","DOI":"10.1074\/jbc.M111.235036","article-title":"The DNA damage response kinases DNA-dependent protein kinase (DNA-PK) and ataxia telangiectasia mutated (ATM) Are stimulated by bulky adduct-containing DNA","volume":"286","author":"Kemp","year":"2011","journal-title":"J Biol Chem"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212001682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212001682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:55:12Z","timestamp":1757768112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295212001682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0006295212001682"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2012.02.026","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2012.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}